Uvisa Health

On a mission to benefit women globally by offering them non-pharmacological solutions for their most intimate health needs.

Need:

Vaginal discomfort is commonly caused by bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), otherwise known as svamp or thrush. But these are often misdiagnosed. Prescription and over-the-counter medications currently serve as the sole solutions. But these medications are not without problems, such as lengthy treatment duration (up to 14 days) and adverse side effects.

Solution:

We're developing a device to simplify how you treat intimate discomfort. Our remedy safely inserts and directs light inside the vagina and over the vulva, eliminating harmful microbes and allowing good bacteria to repopulate. It offers an alternative to pharmacological solutions and transforms how women deal with vaginal infections.

Evidence:

We are currently in the process of gaining medical device certification as a Class IIa device according to the European Medical Device Regulation (MDR), which includes rigorous safety testing and clinical trials.

Business model:

Business Model:

Therapeutic Area: Women's health

Maturity Stage:

Meet the team
  • Coming soon...
What our customers say:

"Repeat infections ruined my life for over a year. Male doctors kept misdiagnosing me. I was so desperate I would have tried anything." Anonymous Sufferer

"I have seen an awful lot of vaginal infections and I think that too much mild bacterial vaginosis is treated with antibiotics which doesn’t resolve problems. I believe light therapy could be effective for patients with recurrent infections as part of a self-care regime." Dr. Annie Neill, Gynaecologist and sexual health doctor, Cambridge University Hospital

"Having a non-pharmacological concept is really important. There are many side effects of antibiotics." Dr. Jørgen Skov Jensen, Head of Reproductive Tract Microbiology, Statens Serum Institut

Let's work together
  • Ella Harris
  • Founder & CEO
Introduce yourself to ELLA today and learn about partnership opportunities.
Next member:
BRAIN+